Pharmaceutical Sciences

Pharmaceutical Sciences Experts

Thomas Dyrberg

Pharmaceutical Sciences
Galera Therapeutics Inc.
United States of America


Dr. Dyrberg is Managing Partner at Novo A/S. He is a member of the Boards of Directors of Delenex Therapeutics AG, Nuvelution Pharma, Inc., Ophthotech Corporation, PanOptica Inc., and Veloxis Pharmaceuticals A/S. Dr. Dyrberg held research positions at the Hagedorn Research Institute, Denmark, and at the Scripps Research Institute, La Jolla, CA, USA. In 1990, he joined Novo Nordisk A/S, initially working in health care discovery on various aspects of diabetes immunology and pathogenesis, and from 1996 in health care clinical drug development. Dr. Dryberg attended the University of Copenhagen, where he obtained an MD degree and a DMSc degree.

Research Interest

Host defense mechanisms,LPS effects on neurotransmitters  

Global Experts from United States of America

Global Experts in Subject